Skip to main content

Table 2 Association of tumour side and clinicopathological parameters

From: Podocalyxin is a marker of poor prognosis in colorectal cancer

Location of the tumour
  Right hemicolon Left hemicolon  
n (%) 227 (27.0) 613 (73.0) p-value
Age, years    
<65 89 (39.2) 271 (44.2) 0.209
≥65 138 (60.8) 342 (55.8)  
Gender    
Male 119 (52.4) 347 (56.6) 0.310
Female 108 (47.6) 266 (43.4)  
Dukes    
A 21 (9.3) 104 (17.0) 0.129
B 85 (37.4) 209 (34.1)  
C 70 (30.8) 161 (26.3)  
D 51 (22.5) 139 (22.7)  
Grade (WHO)    
1 7 (3.1) 22 (3.6) <0.0001
2 127 (56.7) 444 (72.7)  
3 74 (33.0) 128 (20.9)  
4 16 (7.1) 17 (2.8)  
Missing 3 2  
HES9    
Low 189 (89.2) 534 (96.2) <0.001
High 23 (10.8) 21 (3.8)  
Missing 15 58  
  1. Fisher exact-test for 2 × 2 tables and linear-by-linear association test for tables with more than two rows. Missing data excluded from analyses. MAb HES9 recognises PODXL protein.
\